215 related articles for article (PubMed ID: 8537152)
1. The role of nitric oxide and NO-donor agents in myocardial protection from surgical ischemic-reperfusion injury.
Vinten-Johansen J; Sato H; Zhao ZQ
Int J Cardiol; 1995 Jul; 50(3):273-81. PubMed ID: 8537152
[TBL] [Abstract][Full Text] [Related]
2. Basal nitric oxide expresses endogenous cardioprotection during reperfusion by inhibition of neutrophil-mediated damage after surgical revascularization.
Sato H; Zhao ZQ; Jordan JE; Todd JC; Riley RD; Taft CS; Hammon JW; Li P; Ma X; Vinten-Johansen J
J Thorac Cardiovasc Surg; 1997 Feb; 113(2):399-409. PubMed ID: 9040635
[TBL] [Abstract][Full Text] [Related]
3. Reduction in surgical ischemic-reperfusion injury with adenosine and nitric oxide therapy.
Vinten-Johansen J; Zhao ZQ; Sato H
Ann Thorac Surg; 1995 Sep; 60(3):852-7. PubMed ID: 7677546
[TBL] [Abstract][Full Text] [Related]
4. Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury.
Sato H; Zhao ZQ; McGee DS; Williams MW; Hammon JW; Vinten-Johansen J
J Thorac Cardiovasc Surg; 1995 Aug; 110(2):302-14. PubMed ID: 7543634
[TBL] [Abstract][Full Text] [Related]
5. Effect of L-arginine cardioplegia on recovery of neonatal lamb hearts after 2 hours of cold ischemia.
Hiramatsu T; Forbess JM; Miura T; Mayer JE
Ann Thorac Surg; 1995 Nov; 60(5):1187-92. PubMed ID: 8526597
[TBL] [Abstract][Full Text] [Related]
6. Postcardioplegia acute cardiac dysfunction and reperfusion injury.
Vinten-Johansen J; Nakanishi K
J Cardiothorac Vasc Anesth; 1993 Aug; 7(4 Suppl 2):6-18. PubMed ID: 8369469
[TBL] [Abstract][Full Text] [Related]
7. Blood cardioplegia enhanced with nitric oxide donor SPM-5185 counteracts postischemic endothelial and ventricular dysfunction.
Nakanishi K; Zhao ZQ; Vinten-Johansen J; Hudspeth DA; McGee DS; Hammon JW
J Thorac Cardiovasc Surg; 1995 Jun; 109(6):1146-54. PubMed ID: 7776679
[TBL] [Abstract][Full Text] [Related]
8. Coronary artery endothelial dysfunction after global ischemia, blood cardioplegia, and reperfusion.
Nakanishi K; Zhao ZQ; Vinten-Johansen J; Lewis JC; McGee DS; Hammon JW
Ann Thorac Surg; 1994 Jul; 58(1):191-9. PubMed ID: 8037523
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of myocardial ischemia-reperfusion injury with nitric oxide replacement therapy.
Lefer AM
Ann Thorac Surg; 1995 Sep; 60(3):847-51. PubMed ID: 7677545
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of microvascular nitric oxide improves myocardial performance following global ischemia.
Hammon JW; Vinten-Johansen J
J Card Surg; 1995 Jul; 10(4 Suppl):423-7. PubMed ID: 7579837
[TBL] [Abstract][Full Text] [Related]
11. Endothelial and myocardial cell protection by a cysteine-containing nitric oxide donor after myocardial ischemia and reperfusion.
Lefer DJ; Nakanishi K; Vinten-Johansen J
J Cardiovasc Pharmacol; 1993; 22 Suppl 7():S34-43. PubMed ID: 7504767
[TBL] [Abstract][Full Text] [Related]
12. Critical timing of nitric oxide supplementation in cardioplegic arrest and reperfusion.
Engelman DT; Watanabe M; Maulik N; Engelman RM; Rousou JA; Flack JE; Deaton DW; Das DK
Circulation; 1996 Nov; 94(9 Suppl):II407-11. PubMed ID: 8901782
[TBL] [Abstract][Full Text] [Related]
13. Nitrotyrosine and 8-isoprostane formation indicate free radical-mediated injury in hearts of patients subjected to cardioplegia.
Mehlhorn U; Krahwinkel A; Geissler HJ; LaRosee K; Fischer UM; Klass O; Suedkamp M; Hekmat K; Tossios P; Bloch W
J Thorac Cardiovasc Surg; 2003 Jan; 125(1):178-83. PubMed ID: 12539002
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide and the vascular endothelium in myocardial ischemia-reperfusion injury.
Vinten-Johansen J; Zhao ZQ; Nakamura M; Jordan JE; Ronson RS; Thourani VH; Guyton RA
Ann N Y Acad Sci; 1999 Jun; 874():354-70. PubMed ID: 10415547
[TBL] [Abstract][Full Text] [Related]
15. Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunction.
Tofukuji M; Stahl GL; Agah A; Metais C; Simons M; Sellke FW
J Thorac Cardiovasc Surg; 1998 Dec; 116(6):1060-8. PubMed ID: 9832699
[TBL] [Abstract][Full Text] [Related]
16. Blood cardioplegia supplementation with the sodium-hydrogen ion exchange inhibitor cariporide to attenuate infarct size and coronary artery endothelial dysfunction after severe regional ischemia in a canine model.
Muraki S; Morris CD; Budde JM; Zhao ZQ; Guyton RA; Vinten-Johansen J
J Thorac Cardiovasc Surg; 2003 Jan; 125(1):155-64. PubMed ID: 12538999
[TBL] [Abstract][Full Text] [Related]
17. Impaired endothelium-dependent relaxation after cardiac global ischemia and reperfusion: role of warm blood cardioplegia.
Chang CH; Lin PJ; Chu Y; Lee YS
J Am Coll Cardiol; 1997 Mar; 29(3):681-7. PubMed ID: 9060911
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion of dogs.
Lefer DJ; Nakanishi K; Johnston WE; Vinten-Johansen J
Circulation; 1993 Nov; 88(5 Pt 1):2337-50. PubMed ID: 8222127
[TBL] [Abstract][Full Text] [Related]
19. Continuous tepid blood cardioplegia can preserve coronary endothelium and ameliorate the occurrence of cardiomyocyte apoptosis.
Yeh CH; Wang YC; Wu YC; Chu JJ; Lin PJ
Chest; 2003 May; 123(5):1647-54. PubMed ID: 12740286
[TBL] [Abstract][Full Text] [Related]
20. Modulating the Bioactivity of Nitric Oxide as a Therapeutic Strategy in Cardiac Surgery.
Pisarenko O; Studneva I
J Surg Res; 2021 Jan; 257():178-188. PubMed ID: 32835951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
